# Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

> **NCT00622349** · PHASE3 · COMPLETED · sponsor: **European Lung Cancer Working Party** · enrollment: 707 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Cisplatin, Ifosfamide, Gemcitabine
- **DRUG:** Ifosfamide, Gemcitabine
- **DRUG:** Cisplatin, docetaxel

## Key facts

- **NCT ID:** NCT00622349
- **Lead sponsor:** European Lung Cancer Working Party
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2009-03
- **Final completion:** 2009-12
- **Target enrollment:** 707 (ACTUAL)
- **Last updated:** 2013-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00622349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00622349, "Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00622349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*